SCHEMBL7210714

SCHEMBL7210714

CC(C)(C)OC(=O)C(N)c1cccc(N)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 1/20 0.42
CPB2 Q96IY4 1/20 0.42
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRB3 P13945 2/20 0.41
SLC7A5 Q01650 1/20 0.38
ALDH1A1 P00352 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
NR1H2 P55055 1/20 0.35
PBRM1 Q86U86 1/20 0.34
DDX3X O00571 1/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
HPGDS O60760 1/20 0.34
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7336123 0.86 CPN1 (0.43) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL27493979 0.85 ADRB1 (0.40) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL5796124 0.84 APP (0.47) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL8909021 0.84 ADRB1 (0.46) ADRB2ADRB1ADRB3SLC7A5LMNA
SCHEMBL27494783 0.84 ADRB2 (0.40) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL27533952 0.83 SLC7A5 (0.37) SLC7A5ALDH1A1LMNAKMT2AATM
SCHEMBL7347467 0.82 CPN1 (0.47) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL7461910 0.82 CPN1 (0.47) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL7461918 0.82 CPN1 (0.40) CPN1CPB2ADRB2ADRB1ADRB3
SCHEMBL28741995 0.82 CPN1 (0.40) CPN1CPB2ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed